A global maker of starches and sweeteners, transforming plant-based materials like corn into ingredients used in foods, beverages, and brewing. It traces back to the Corn Products Refining Company, formed in 1906, which gave the world pantry staples like Karo syrup and Mazola corn oil. In 2012 it renamed itself Ingredion—a blend of "ingredients" and a Greek word meaning "something that goes"—to reflect its move toward health-focused ingredients.
Ingredion elects Diego Reynoso as EVP and CFO, effective October 1, 2026
Jason Payant will cease serving as Interim CFO on October 1, 2026, and will continue as Vice President, Finance, Global Texture & Healthful Solutions.
Show detailsHide details
On August 19, 2026, Ingredion's Board elected Diego Reynoso as Executive Vice President and Chief Financial Officer, effective October 1, 2026.
Reynoso joins from The Boston Beer Company, where he was CFO from September 2023 to September 2026, with over 25 years of finance experience.
His compensation includes a $725,000 base salary, 90% target annual cash incentive, a $770,000 sign-on cash award, and sign-on equity grants valued at $1.3 million and $700,000.
He will participate in the company's Executive Severance Plan and Executive Change in Control Severance Plan, and will enter a standard indemnification agreement.
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
The acquisition was announced on June 8, 2026, and is to be implemented via a court-sanctioned scheme under Part 26 of the UK Companies Act 2026.
Show detailsHide details
On July 28, 2026, Tate & Lyle PLC shareholders voted to approve the scheme of arrangement and related resolutions for Ingredion's all-cash acquisition.
Completion is expected in the second half of 2027, subject to remaining conditions including antitrust approvals and court sanction.
The approval satisfies a condition to completion of the acquisition.
The report was furnished under Item 7.01 Regulation FD Disclosure and is not deemed filed for SEC purposes.
Ingredion completes sale of 51% of Rafhan Maize for ~$165 million cash
Ingredion completed the sale of 51% of Rafhan Maize Products Co. Ltd. to affiliates of the Nishat Group led by Nishat Hotels and Properties Limited on June 30, 2026.
Show detailsHide details
Ingredion received approximately $165 million in cash (U.S. dollars) as aggregate consideration.
Rafhan Maize generated approximately $250 million in net sales in 2025 and is not in a reportable segment.
The Purchaser acquired about 78% of Rafhan Maize's outstanding shares, including Ingredion's 51% stake; Ingredion retains an approximately 20% minority interest.
Ingredion and the Purchaser entered a shareholders agreement with a put option exercisable from the fifth year after closing, plus manufacturing/supply and distribution agreements.
Ingredion enters $1.475B delayed draw term loan to fund Tate & Lyle acquisition
On June 24, 2026, Ingredion entered a Delayed Draw Term Loan Agreement with JPMorgan Chase Bank as administrative agent, providing a $1.475 billion senior unsecured facility in two tranches: $500 million (Tranche A-1) and $975 million (Tranche B-1).
Show detailsHide details
Proceeds will fund the cash consideration for Ingredion's offer to purchase all share capital of Tate & Lyle PLC, refinance certain Tate & Lyle indebtedness, and pay related fees and expenses.
The loan commitments automatically terminate on February 2, 2028, extendable to August 3, 2028, and lenders are restricted from actions that would prevent funding for the acquisition until that date or specified draw-stop events.
Tranche A-1 loans mature three years after funding; Tranche B-1 loans mature five years after funding; both amortize quarterly at 5% per annum of outstanding principal, with prepayment allowed without premium or penalty.
The facility includes financial covenants: a maximum leverage ratio of 3.5 to 1.0 (increasing to 4.0 to 1.0 for four quarters after a material acquisition) and a minimum interest coverage ratio of 3.5 to 1.0.
1.01 Entry into a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · 9.01 Financial Statements and Exhibits
Leadership8-K
Ingredion elects Kenneth Escoe to its board, effective July 1, 2026.
The Board determined Escoe qualifies as an independent director under NYSE standards.
Show detailsHide details
On June 7, 2026, Ingredion's Board elected Kenneth Escoe as a director, with his term starting July 1, 2026.
Escoe, 51, is Executive Vice President of Specialty Products at Illinois Tool Works Inc., a role he has held since 2020.
He will receive the standard non-management director compensation: annual cash and equity retainers in restricted stock units under the company's stock incentive plan.
Ingredion will enter into its standard form of director indemnification agreement with Escoe.
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Ingredion to acquire Tate & Lyle for £2.7bn cash, ~$3.6bn
Ingredion and Tate & Lyle boards agreed to a recommended cash offer of 595 pence per Tate & Lyle share, totaling approximately £2.7 billion (~$3.6 billion).
Show detailsHide details
The acquisition will be implemented via a court-sanctioned scheme of arrangement under the UK Companies Act, with completion expected in the second half of 2027.
Tate & Lyle shareholders may also receive permitted dividends up to 13.2 pence final and 6.8 pence interim.
Ingredion secured a $4.225 billion 364-day bridge loan facility from JPMorgan to fund the cash consideration and related costs.
Huber Equity Corporation, owning ~16.8% of Tate & Lyle shares, and Tate & Lyle directors (~0.3%) have given irrevocable undertakings to support the deal.
1.01 Entry into a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits